Cantargia's CAN10 demonstrates positive activity in systemic sclerosis models in new data presented at ACR Convergence 2 (Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating positive effects of the IL1RAP-binding antibody CAN10 in three different in vivo models of systemic sclerosis, a lead indication for the drug candidate.
The proposal of Valmet's Shareholders' Nomination Board for the composition and remuneration of the Board of Directors
Norwegian Minister of Petroleum and Energy raises Vianode flag at site of new battery materials plant
El barco Plastic Odyssey inicia una travesía de tres años para luchar contra la contaminación marítima por plástico
